PURPOSE: @entity0 has a poorer prognosis among black @entity1 than among white @entity1 . This review was conducted to determine whether this disparity reflects the direct impact of race on likelihood of cure or on time to @entity204 from @entity0 or stems from the interaction of race with @entity5 stage and @entity1 age. @entity1 AND METHODS: We analyzed data from 115,838 @entity1 with localized (node-negative) and regionally metastatic (node-positive) @entity0 from the Surveillance, Epidemiology, and End-Results (SEER) Program of the National @entity5 Institute. Parametric analysis was used to determine the independent prognostic value of age, stage, and race. Linear regression and distribution analyses were also used to examine the interaction of these covariates. RESULTS: The prevalence of regionally metastatic disease, relative to @entity66 , declined with increased age among white @entity1 and those classified as "other," but remained relatively constant among black @entity1 . Parametric analysis showed a smaller cured fraction and shorter time to @entity204 when @entity1 with regional disease were compared with those with @entity66 . A similar disparity was found when black @entity1 were compared with those classified as white or other. CONCLUSION: Age and race have a significant association with @entity5 stage. In addition, our data show that race has an independent impact on the clinical course of @entity0 and diminishes both the likelihood of cure and time to @entity204 among uncured @entity1 .

XXXX : the survival impact of race.

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'patient', 'PATIENTS'] @entity66 :: ('MESH:D004194', 'Disease') :: ['localized disease'] @entity0 :: ('MESH:D001943', 'Disease') :: ['Breast cancer', 'breast cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'Cancer'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity0 :: (MESH:D001943,Disease) :: ['Infiltrating ductal carcinoma of the breast']
